Kenn Gerdes & Hanne Ingmer
Nature 503, 347–349 (21 November 2013)
Expediting Drug Development — The FDA's New “Breakthrough Therapy” Designation
Rachel E. Sherman, M.D., M.P.H., Jun Li, J.D., Ph.D., Stephanie Shapley, M.B.A., Melissa Robb, R.N., and Janet Woodcock, M.D.
N Engl J Med 2013; 369:1877-1880
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol: A Fresh Interpretation of Old Evidence
Bruce M. Psaty, MD, PhD1,2; Noel S. Weiss, MD, DrPH
JAMA. Published online November 21, 2013. doi:10.1001/jama.2013.284203
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, M.D., et al
N Engl J Med 2013; 369:2093-2104
The patent bargain: An open-source patent database highlights the need for more transparency worldwide.
Nature 504, 187–188 (12 December 2013)
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets
Justin M. Drake et al
PNAS December 3, 2013 vol. 110 no. 49 E4762-E4769